<DOC>
	<DOC>NCT01267305</DOC>
	<brief_summary>The purpose of this study is to determine whether the use of different dose of LMWH compared with fondaparinux for thromboprophylaxis is efficacious and safety after thoracic surgery.</brief_summary>
	<brief_title>The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic Surgery</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Calcium, Dietary</mesh_term>
	<mesh_term>Fondaparinux</mesh_term>
	<mesh_term>PENTA</mesh_term>
	<mesh_term>Anticoagulants</mesh_term>
	<mesh_term>Nadroparin</mesh_term>
	<criteria>clinical diagnosis of esophageal carcinoma and planned for esophagectomy clinical diagnosis of lung carcinoma and planned for lung resection general anesthesia combined with epidural anesthesia blood clotting disfunction before surgery anticoagulating or antiplatelet history before surgery low blood platelets count hemorrhagic disease cerebral hemorrhage cerebral,spinal,ophthalmologic operation history peptic ulcer bleeding&gt;400ml in operation bleeding&gt;100ml/h after operation blood transfusion in or after operation severe renal or liver disfunction severe hypertension</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>esophagectomy</keyword>
	<keyword>lung resection</keyword>
	<keyword>venous thromboembolism</keyword>
	<keyword>low molecular weight heparin</keyword>
	<keyword>chest drainage</keyword>
	<keyword>TEG</keyword>
</DOC>